Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.
Welcome to Company ecrins-therapeutics's Biochemistry Lab
Drug Discovery & Development
Leader in Biochemistry Research, we’re helping companies of all sizes to achieve their research goals and make a positive impact on society.
Research & Development
With years of experience in biochemistry research, we have successfully developed a range of products and services for clients around the world.
